Atigotatug

BMS-986489 · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atigotatug, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) [Phase 2]